Optic Nerve Glioma - 25 Studies Found
Completed |
: Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy :
: 2008-05-14 : |
Active, not recruiting |
: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma :
|
Terminated |
: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas :
: Drug: Sorafenib (Nexavar) Sorafenib (in tablet form) will |
Recruiting |
: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma :
|
Recruiting |
: Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors :
|
Active, not recruiting |
: Pomalidomide in Treating Younger Patients With Recurrent, Progressive or Refractory Central Nervous System Tumors :
|
Withdrawn |
: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors :
|
Terminated |
: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas :
|
Terminated |
: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia :
|
Completed |
: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors :
|